During the last years the pharmaceutical industry in Brazil, went through important transformations. We have seen the growth of national companies – leveraged in large part by the production of generic drugs – the repositioning of foreign industries – as a result of new technologies for the production of biological medicines – and the proliferation of public-private partnerships. These transformations had on the background changes of government and still the reflections of the last global recession.
We noted with concern the departure of specialized engineering companies in the pharmaceutical market and the creation of a large gap in the segment. Many of the professionals in the business have changed their activity or left the country in search of opportunities.
In 2019 we are closely monitoring the pharmaceutical regulatory framework and the harmonization of Brazilian standards with international standards through participation in PIC/S and ICH. This normative change will certainly come accompanied by the need for business adequacy and consequent demand for specialized consulting services.
In short, the pharmaceutical engineering market in Brazil is increasingly dynamic and companies working in this segment need to adapt in the same way. That is why Nordika do Brasil has decided to invest part of its best resources in the creation of a consulting division specialized in solutions for the pharmaceutical industry – welcome to Nordika Consulting.
The main objective of Nordika Consulting is to offer services of high added value, developed by highly qualified professionals. We are prepared to offer the following specialized activities:
years of experience in Brazil
Thousand Hours of Engineering Done
Thousand m² of projected area
© 2022 All Rights Reserved. Nordika